Kestra Advisory Services, LLC Novo Nordisk A S Transaction History

Kestra Advisory Services, LLC

$17.6 Billion
Q2 2024

A detailed history of Kestra Advisory Services, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 145,095 shares of NVO stock, worth $17.5 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

145,095

Previous 124,616 16.43%

Holding current value

$17.5 Million

Previous $16 Million 29.44%

% of portfolio

0.12%

Previous 0.11%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $2.51 Million - $3.01 Million	20,479 Added 16.43%	145,095 $20.7 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $2.41 Million - $3.21 Million	23,641 Added 23.41%	124,616 $16 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $1.83 Million - $2.19 Million	20,792 Added 25.93%	100,975 $10.4 Million
Q3 2023 Nov 09, 2023	BUY	$90.94 - $199.54 $5 Million - $11 Million	55,003 Added 218.44%	80,183 $7.29 Million
Q2 2023 Aug 11, 2023	BUY	$155.98 - $172.65 $322,254 - $356,694	2,066 Added 8.94%	25,180 $4.07 Million
Q1 2023 May 12, 2023	SELL	$132.34 - $159.14 $3.26 Million - $3.92 Million	-24,615 Reduced 51.57%	23,114 $3.68 Million
Q4 2022 Jan 31, 2023	BUY	$102.55 - $135.33 $537,259 - $708,993	5,239 Added 12.33%	47,729 $6.46 Million
Q3 2022 Nov 01, 2022	BUY	$95.28 - $116.93 $269,451 - $330,678	2,828 Added 7.13%	42,490 $4.23 Billion
Q2 2022 Aug 12, 2022	BUY	$103.24 - $121.81 $1.81 Million - $2.14 Million	17,562 Added 79.47%	39,662 $4.42 Million
Q1 2022 Apr 26, 2022	BUY	$93.1 - $112.54 $292,240 - $353,263	3,139 Added 16.56%	22,100 $2.45 Million
Q4 2021 Jan 20, 2022	SELL	$95.88 - $117.08 $367,891 - $449,235	-3,837 Reduced 16.83%	18,961 $2.12 Million
Q3 2021 Oct 19, 2021	BUY	$84.42 - $106.62 $276,475 - $349,180	3,275 Added 16.78%	22,798 $2.19 Million
Q2 2021 Jul 28, 2021	BUY	$67.66 - $84.76 $9,404 - $11,781	139 Added 0.72%	19,523 $1.64 Million
Q1 2021 May 10, 2021	BUY	$67.06 - $75.82 $560,152 - $633,324	8,353 Added 75.72%	19,384 $1.31 Million
Q4 2020 Jan 20, 2021	BUY	$63.89 - $73.8 $699,595 - $808,110	10,950 Added 13518.52%	11,031 $774 Million
Q3 2020 Nov 12, 2020	BUY	$63.69 - $70.22 $5,158 - $5,687	81 New	81 $372 Million

Others Institutions Holding NVO

# of Institutions

1,991

Shares Held

318M

Call Options Held

5.23M

Put Options Held

4.97M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $273B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.

Account

Kestra Advisory Services, LLC Novo Nordisk A S Transaction History